AI could slash Alzheimer's scans: one test instead of two

NCT ID NCT07431255

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new AI method to generate a type of brain scan (FDG PET) from another scan (amyloid PET) and an MRI, without needing an extra injection or scan. Researchers will use data from 35 Alzheimer's patients who already had both scans. If it works, it could reduce radiation, cost, and time for future patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this AI method could eliminate the need for a separate FDG PET scan, reducing radiation exposure, cost, and time for Alzheimer's diagnosis.

What could go wrong

This is a small, early-stage study using existing data, not a treatment trial. The AI may not work accurately across different patients or scanners.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE (AD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • IRCCS Ospedale San Raffaele

    Milan, Lombardy, 20132, Italy